Diamyd Medical announces expanded financial support from Breakthrough T1D

STOCKHOLM, Feb. 12, 2025 /PRNewswire/ -- Diamyd Medical will receive USD 1.75 million in expanded collaboration support from Breakthrough T1D (formerly JDRF), the world's leading Type 1 Diabetes research and advocacy organization, in support of the DIAGNODE-3 Phase 3 trial to facilitate...